320 Phase IIa study of alpha-DC1 vaccine against HER2/HER3, chemokine modulation regimen and pembrolizumab in patients with asymptomatic brain metastasis from triple negative or HER2+ breast cancer
oleh: Pawel Kalinski, Peter Forsyth, Mateusz Opyrchal, Hung Khong, Amy Early, Brian Czerniecki, Shipra Gandhi, Kamran Ahmed, Kristopher Attwood, Ellis Levine, Tracey O’Connor, Robert Fenstermaker, Dheerendra Prasad, Kazuaki Takabe
| Format: | Article |
|---|---|
| Diterbitkan: | BMJ Publishing Group 2020-11-01 |
Deskripsi
No description available for this item.